FDA Inspection 1051240 — Catalent U.K. Swindon Zydis Limited
The FDA completed an inspection of Catalent U.K. Swindon Zydis Limited on Sep 15, 2016 in Swindon. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Swindon (United Kingdom)
Additional details
Mutual Recognition Agreement (MRA)